Jasper Therapeutics Inc (JSPR) — Financial Flexibility Index
Jasper Therapeutics Inc (JSPR) has a Financial Flexibility Index of -0.82x as of March 2026. Free cash flow of $-14.55 Million (operating CF $-14.55 Million minus capex $0.00) represents -1% of total liabilities ($17.78 Million). Check JSPR strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jasper Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Jasper Therapeutics Inc across 7 annual periods. See JSPR working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jasper Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Jasper Therapeutics Inc. For the full company profile including market capitalisation, see Jasper Therapeutics Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.44x | $-77.15 Million | $-77.16 Million | $31.63 Million | ▲ +28.4% |
| 2024 | -3.40x | $-62.05 Million | $-62.60 Million | $18.23 Million | ▼ -8.1% |
| 2023 | -3.15x | $-51.80 Million | $-52.07 Million | $16.45 Million | ▲ +14.0% |
| 2022 | -3.66x | $-45.28 Million | $-45.86 Million | $12.37 Million | ▼ -182.7% |
| 2021 | -1.29x | $-31.25 Million | $-33.68 Million | $24.14 Million | ▼ -378.1% |
| 2020 | -0.27x | $-15.84 Million | $-18.27 Million | $58.49 Million | ▼ -460.4% |
| 2019 | 0.08x | $459.00K | $-1.97 Million | $6.11 Million | — |